Latest Innovation News

Aerometrex Limited has reported a robust half-year performance with record revenue growth and a dramatic increase in EBITDA, signalling strong operational momentum as it advances its SaaS transition.

Locksley Resources has initiated diamond drilling at its Desert Antimony Mine in California, aiming to expand known high-grade mineralisation and support US critical minerals supply chains.

Clarity Pharmaceuticals reports another metastatic prostate cancer patient achieving undetectable disease markers in its Phase II SECuRE trial, reinforcing promising efficacy and safety of its Cu-SAR-bisPSMA radiopharmaceutical.

Praemium Limited reported a robust half-year performance with a 69.5% jump in net profit and a 9.6% rise in funds under administration, completing the OneVue platform transition and acquiring AI specialist Technotia Laboratories.

EVT Limited reported a robust first half for 2026 with revenue rising 5.4% to A$683.8 million and net profit up 21.6%, driven by strong performances in Germany, Thredbo, and Hotels. Strategic acquisitions, including Pro-invest Hotels and QT Auckland, underpin the group’s growth ambitions.

Pharmx Technologies has entered a multi-year strategic alliance with Sigma Healthcare, becoming the preferred EDI provider for Sigma and Chemist Warehouse across Australia and New Zealand, while Sigma takes a significant equity stake.

IMDEX Limited has reported its strongest first half ever, with revenue climbing 16% to $247 million, driven by robust market share gains and key acquisitions that broaden its mining technology portfolio.

Cash Converters International Limited reported an 8% rise in half-year revenue to $206.7 million, driven by franchise acquisitions and a shift in lending strategy. Despite a 17% dip in net profit due to one-off costs, the company declared a fully franked interim dividend and reinstated its Dividend Reinvestment Plan.

Legend Mining has received an $811,458 cash refund from the Australian Taxation Office for its FY2025 R&D claim, lifting its cash position to nearly $11 million.

McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.

Fisher & Paykel Healthcare has raised its full-year revenue and profit forecasts for FY26, buoyed by strong hospital product growth and favourable exchange rates, while navigating the complexities of a recent US Supreme Court tariff ruling.

PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.